Search Results

Senators Mike Crapo, Michael Bennet, Tim Scott, and Ben Cardin introduced the Medicare Multi-Cancer Early Detection Screening Coverage Act (S. 2085) last week. This important legislation provides Medicare with the authority to cover the latest innovative cancer screening technologies once they have been approved by the Food and Drug Administration. With these MCED tests, clinicians will be able to …

The Association of Community Cancer Centers (ACCC) is highly concerned about the ongoing shortages of platinum-based chemotherapy agents (e.g., cisplatin and carboplatin), two medications that (individually or in combination) treat and cure a wide range of cancers, including but not limited to gastric, pancreatic, colorectal, esophageal, cervical, and ovarian.

The Association of Community Cancer Centers (ACCC) is grateful that Congress is poised to address many of our year-end policy priorities in its proposed fiscal year 2023 omnibus appropriations package released this week.

In the wake of the Supreme Court’s recent decision on Dobbs overturning its 1973 ruling on Roe v. Wade, the Association of Community Cancer Centers (ACCC) has become increasingly concerned with the impact this decision may have on patients with cancer and their care teams.

The Association of Community Cancer Centers (ACCC) is pleased that the Centers for Medicare & Medicaid Services (CMS) has announced a new, voluntary alternative payment model as a successor to the Oncology Care Model (OCM), which is due to sunset later this month.

Multidisciplinary cancer care leaders, including physicians, nurses, pharmacists, program administrators, social workers, financial advocates, and patient navigators, from all across the country are meeting with congressional offices today to advocate for policies that support their patients as part of the Association of Community Cancer Centers’ (ACCC) 2022 Virtual Hill Day.

Health plans and pharmacy benefit managers should find ways to support treatment decisions made by cancer care providers and their patients rather than limiting where, how, and which drugs can be administered.

The Association of Community Cancer Centers (ACCC) commends Congress for including the extension of Medicare telehealth waivers in fiscal year 2022 omnibus legislation passed by both chambers this week.

ACCC applauds President Biden for renewing the Cancer Moonshot and setting the ambitious goals of reducing cancer mortality while improving the experience of patients living with cancer.

The Association of Community Cancer Centers (ACCC) announced today that Matt Devino, MPH has joined the organization as Director, Cancer Care Delivery and Health Policy.

ACCC believes that to improve the current treatment options available for patients at the lowest cost without decreasing access to care, certain principles should be taken into consideration.

As the leading education and advocacy organization for the cancer care community, ACCC recognizes that our members are treating an increasing number of Americans with late-stage cancer diagnoses. We believe this legislation will help patients and providers access the necessary technologies to detect cancer earlier.

The lawsuit, filed on December 4, 2020 asserted that the Most Favored Nation (MFN) Interim Final Rule exceeded the statutory authority provided to CMS and improperly failed to follow required rulemaking procedures.

Washington, D.C. (December 23, 2020)— A federal court issued a temporary restraining order (TRO) blocking the Center for Medicare & Medicaid Services from implementing its Most Favored Nation (MFN) Interim Final Rule on January 1, 2021. The TRO is part of a lawsuit filed December 4, 2020 by the Association of Community Cancer Centers (ACCC), the Pharmaceutical Research and Manufacturers of America …

WASHINGTON, D.C. (December 4, 2020) – Today, the Pharmaceutical Research and Manufacturers of America (PhRMA), the Association of Community Cancer Centers (ACCC), the Global Colon Cancer Association (GCCA) and National Infusion Center Association (NICA) filed a lawsuit in the U.S. District Court for the District of Maryland asserting that the Most Favored Nation (MFN) Interim Final Rule exceeds the …

On November 20, the Centers for Medicare and Medicaid Services (CMS) released the Most Favored Nation (MFN) Model Interim Final Rule with Comment Period (IFC). While the Association of Community Cancer Centers (ACCC) acknowledges the effort of the Trump Administration to address rising drug costs, we strongly urge CMS to withdraw the MFN model. A policy that ties Medicare payment for outpatient drugs …

ROCKVILLE, Md. – The Association of Community Cancer Centers (ACCC) applauds Senators Franken (D–MN) and Kirk (R–IL) and Congressmen Higgins (D–NY) and Lance (R–NJ) for introducing companion bills, S 1566/ HR 2739, last week to equalize out–of–pocket costs for cancer patients choosing between oral and intravenous (IV) chemotherapy therapies. This bipartisan, bicameral effort would require health plans …

Rockville, Md. – ACCC applauds the 92 Senators and 392 House members who voted “yes” on H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015. This bipartisan, bicameral compromise took remarkable leadership on both sides of the aisle and finally provides physicians with the predictable, appropriate payments they need to continue to provide high-quality cancer care. "Last night’s historic …

ROCKVILLE, Md. – Last week the Center for Medicare and Medicaid Innovation (CMMI) at the Centers for Medicare & Medicaid Services (CMS) announced its much-anticipated Oncology Care Model (OCM), a new voluntary program for physician–led practices to test the bundling of payments for chemotherapy administration. The OCM is the second specialty care model to be announced at CMMI, and the first in …